These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 23681899)

  • 1. [Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
    Angelberger S; Campregher C; Fuchssteiner H; Gasche C; Gröchenig HP; Haas T; Kazemi-Shirazi L; Mayer A; Miehsler W; Platzer R; Reinisch W; Steiner P; Tilg H; Tillinger W; Vogelsang H; Novacek G
    Z Gastroenterol; 2013 May; 51(5):450-7. PubMed ID: 23681899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance strategies in inflammatory bowel disease.
    Schmidt C; Bielecki C; Felber J; Stallmach A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):189-201. PubMed ID: 20485256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation in inflammatory bowel disease - surveillance guide.
    Stallmach A; Bielecki C; Schmidt C
    Dig Dis; 2009; 27(4):584-90. PubMed ID: 19897979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endoscopy in IBD. A Consensus Report of the IBD Working of the Austrian Association of Gastroenterology and Hepatology].
    Petritsch W; Tillinger W; Vogelsang H; Reinisch W; Knoflach P; Tilg H
    Z Gastroenterol; 2006 Nov; 44(11):1183-92. PubMed ID: 17115362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA; Polyak S
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
    Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
    Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: attitudes and practice.
    Verschuren EC; Ong DE; Kamm MA; Desmond PV; Lust M
    Intern Med J; 2014 Jan; 44(1):40-9. PubMed ID: 24015799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease cancer risk, detection and surveillance.
    Rogler G
    Dig Dis; 2012; 30 Suppl 2():48-54. PubMed ID: 23207932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States.
    Wang YR; Cangemi JR; Loftus EV; Picco MF
    Am J Gastroenterol; 2013 Mar; 108(3):444-9. PubMed ID: 23295277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease.
    Shergill AK; Farraye FA
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):469-81. PubMed ID: 24975537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nutrition and IBD-Consensus of the Austrian Working Group of IBD (Inflammatory Bowel Diseases) of the ÖGGH].
    Fuchssteiner H; Nigl K; Mayer A; Kristensen B; Platzer R; Brunner B; Weiß I; Haas T; Benedikt M; Gröchenig HP; Eisenberger A; Hillebrand P; Reinisch W; Vogelsang H
    Z Gastroenterol; 2014 Apr; 52(4):376-86. PubMed ID: 24718944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [British and American screening guidelines inadequate for prevention of colorectal carcinoma in patients with inflammatory bowel disease].
    Vleggaar FP; Lutgens MW; Oldenburg B; Schipper ME; Samsom M
    Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2787-91. PubMed ID: 18232199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of colorectal cancer risk in patients with Crohn's disease.
    Lichtenstein GR
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S16-24. PubMed ID: 12478240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention for colon cancer: new opportunities, fact or fiction?
    Terhaar Sive Droste JS; Tuynman JB; Van Dullemen HM; Mulder CJ
    Scand J Gastroenterol Suppl; 2006; (243):158-64. PubMed ID: 16782636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.
    Clarke WT; Feuerstein JD
    World J Gastroenterol; 2019 Aug; 25(30):4148-4157. PubMed ID: 31435169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
    Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
    Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
    Viennot S; Deleporte A; Moussata D; Nancey S; Flourié B; Reimund JM
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S190-201. PubMed ID: 20117342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Cancer Screening in Inflammatory Bowel Disease.
    Sengupta N; Yee E; Feuerstein JD
    Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.